» Articles » PMID: 34669463

Computational Repurposing of Therapeutic Small Molecules from Cancer to Pulmonary Hypertension

Abstract

Cancer therapies are being considered for treating rare noncancerous diseases like pulmonary hypertension (PH), but effective computational screening is lacking. Via transcriptomic differential dependency analyses leveraging parallels between cancer and PH, we mapped a landscape of cancer drug functions dependent upon rewiring of PH gene clusters. Bromodomain and extra-terminal motif (BET) protein inhibitors were predicted to rely upon several gene clusters inclusive of galectin-8 (LGALS8). Correspondingly, LGALS8 was found to mediate the BET inhibitor–dependent control of endothelial apoptosis, an essential role for PH in vivo. Separately, a piperlongumine analog’s actions were predicted to depend upon the iron-sulfur biogenesis gene ISCU. Correspondingly, the analog was found to inhibit ISCU glutathionylation, rescuing oxidative metabolism, decreasing endothelial apoptosis, and improving PH. Thus, we identified crucial drug-gene axes central to endothelial dysfunction and therapeutic priorities for PH. These results establish a wide-ranging, network dependency platform to redefine cancer drugs for use in noncancerous conditions.

Citing Articles

Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension.

Rao R, Yang J, Jiang S, El-Khoury W, Hafeez N, Okawa S Am J Physiol Lung Cell Mol Physiol. 2024; 328(1):L148-L158.

PMID: 39657959 PMC: 11905863. DOI: 10.1152/ajplung.00048.2024.


Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension.

Rao R, Yang J, Jiang S, El-Khoury W, Hafeez N, Okawa S bioRxiv. 2024; .

PMID: 39345560 PMC: 11429958. DOI: 10.1101/2024.09.19.613988.


Genetics and precision genomics approaches to pulmonary hypertension.

Austin E, Aldred M, Alotaibi M, Graf S, Nichols W, Trembath R Eur Respir J. 2024; 64(4).

PMID: 39209481 PMC: 11525347. DOI: 10.1183/13993003.01370-2024.


CytoCellDB: a comprehensive resource for exploring extrachromosomal DNA in cancer cell lines.

Fessler J, Ting S, Yi H, Haase S, Chen J, Gulec S NAR Cancer. 2024; 6(3):zcae035.

PMID: 39091515 PMC: 11292414. DOI: 10.1093/narcan/zcae035.


[Research progress on bioinformatics in pulmonary arterial hypertension].

Peng W, Zhang Z, Xiao Y Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(4):425-431.

PMID: 38660909 PMC: 11057300. DOI: 10.7499/j.issn.1008-8830.2310076.


References
1.
Chaidos A, Caputo V, Gouvedenou K, Liu B, Marigo I, Chaudhry M . Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. Blood. 2013; 123(5):697-705. DOI: 10.1182/blood-2013-01-478420. View

2.
Park K . A review of computational drug repurposing. Transl Clin Pharmacol. 2020; 27(2):59-63. PMC: 6989243. DOI: 10.12793/tcp.2019.27.2.59. View

3.
Tew K, Townsend D . Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metab Rev. 2011; 43(2):179-93. PMC: 4603649. DOI: 10.3109/03602532.2011.552912. View

4.
Launay G, Salza R, Multedo D, Thierry-Mieg N, Ricard-Blum S . MatrixDB, the extracellular matrix interaction database: updated content, a new navigator and expanded functionalities. Nucleic Acids Res. 2014; 43(Database issue):D321-7. PMC: 4383919. DOI: 10.1093/nar/gku1091. View

5.
Bertero T, Lu Y, Annis S, Hale A, Bhat B, Saggar R . Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. J Clin Invest. 2014; 124(8):3514-28. PMC: 4109523. DOI: 10.1172/JCI74773. View